186 related articles for article (PubMed ID: 21665470)
21. Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosis.
Pappalardi MB; Martin JD; Jiang Y; Burns MC; Zhao H; Ho T; Sweitzer S; Lor L; Schwartz B; Duffy K; Gontarek R; Tummino PJ; Copeland RA; Luo L
Biochemistry; 2008 Oct; 47(43):11165-7. PubMed ID: 18834144
[TBL] [Abstract][Full Text] [Related]
22. Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
Tuckerman JR; Zhao Y; Hewitson KS; Tian YM; Pugh CW; Ratcliffe PJ; Mole DR
FEBS Lett; 2004 Oct; 576(1-2):145-50. PubMed ID: 15474027
[TBL] [Abstract][Full Text] [Related]
23. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
Flashman E; Davies SL; Yeoh KK; Schofield CJ
Biochem J; 2010 Mar; 427(1):135-42. PubMed ID: 20055761
[TBL] [Abstract][Full Text] [Related]
24. DNA methylation analysis of the HIF-1α prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
Huang KT; Mikeska T; Dobrovic A; Fox SB
Histopathology; 2010 Sep; 57(3):451-60. PubMed ID: 20727020
[TBL] [Abstract][Full Text] [Related]
25. Determination and modulation of prolyl-4-hydroxylase domain oxygen sensor activity.
Wirthner R; Balamurugan K; Stiehl DP; Barth S; Spielmann P; Oehme F; Flamme I; Katschinski DM; Wenger RH; Camenisch G
Methods Enzymol; 2007; 435():43-60. PubMed ID: 17998048
[TBL] [Abstract][Full Text] [Related]
26. [Reciprocal regulation between hypoxia-inducible factor-1alpha and its prolyl hydroxylases in hypoxic pulmonary hypertension rats].
Chen YR; Dai AG; Hu RC
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):668-73. PubMed ID: 17129494
[TBL] [Abstract][Full Text] [Related]
27. Differences in hydroxylation and binding of Notch and HIF-1alpha demonstrate substrate selectivity for factor inhibiting HIF-1 (FIH-1).
Wilkins SE; Hyvärinen J; Chicher J; Gorman JJ; Peet DJ; Bilton RL; Koivunen P
Int J Biochem Cell Biol; 2009 Jul; 41(7):1563-71. PubMed ID: 19401150
[TBL] [Abstract][Full Text] [Related]
28. Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase.
Jeon H; Kim H; Choi D; Kim D; Park SY; Kim YJ; Kim YM; Jung Y
Mol Pharmacol; 2007 Jun; 71(6):1676-84. PubMed ID: 17377063
[TBL] [Abstract][Full Text] [Related]
29. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
30. Cloning and characterization of the rat HIF-1 alpha prolyl-4-hydroxylase-1 gene.
Cobb RR; McClary J; Manzana W; Finster S; Larsen B; Blasko E; Pearson J; Biancalana S; Kauser K; Bringmann P; Light DR; Schirm S
Protein Expr Purif; 2005 Aug; 42(2):295-304. PubMed ID: 15925519
[TBL] [Abstract][Full Text] [Related]
31. Molecular evolution of the metazoan PHD-HIF oxygen-sensing system.
Rytkönen KT; Williams TA; Renshaw GM; Primmer CR; Nikinmaa M
Mol Biol Evol; 2011 Jun; 28(6):1913-26. PubMed ID: 21228399
[TBL] [Abstract][Full Text] [Related]
32. Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway.
Hirsilä M; Koivunen P; Xu L; Seeley T; Kivirikko KI; Myllyharju J
FASEB J; 2005 Aug; 19(10):1308-10. PubMed ID: 15941769
[TBL] [Abstract][Full Text] [Related]
33. Age-dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart.
Rohrbach S; Simm A; Pregla R; Franke C; Katschinski DM
Biogerontology; 2005; 6(3):165-71. PubMed ID: 16041620
[TBL] [Abstract][Full Text] [Related]
34. An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α.
Nepal M; Gong YD; Park YR; Soh Y
Cell Biochem Funct; 2011 Mar; 29(2):126-34. PubMed ID: 21287578
[TBL] [Abstract][Full Text] [Related]
35. Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3.
Huang J; Zhao Q; Mooney SM; Lee FS
J Biol Chem; 2002 Oct; 277(42):39792-800. PubMed ID: 12181324
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor.
Barrett TD; Palomino HL; Brondstetter TI; Kanelakis KC; Wu X; Haug PV; Yan W; Young A; Hua H; Hart JC; Tran DT; Venkatesan H; Rosen MD; Peltier HM; Sepassi K; Rizzolio MC; Bembenek SD; Mirzadegan T; Rabinowitz MH; Shankley NP
Mol Pharmacol; 2011 Jun; 79(6):910-20. PubMed ID: 21372172
[TBL] [Abstract][Full Text] [Related]
37. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
Schneider C; Krischke G; Keller S; Walkinshaw G; Arend M; Rascher W; Gassmann M; Trollmann R
Brain Res; 2009 Jul; 1280():43-51. PubMed ID: 19450570
[TBL] [Abstract][Full Text] [Related]
38. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression.
McMahon S; Charbonneau M; Grandmont S; Richard DE; Dubois CM
J Biol Chem; 2006 Aug; 281(34):24171-81. PubMed ID: 16815840
[TBL] [Abstract][Full Text] [Related]
40. Prolyl hydroxylase domain protein 2 (PHD2) binds a Pro-Xaa-Leu-Glu motif, linking it to the heat shock protein 90 pathway.
Song D; Li LS; Heaton-Johnson KJ; Arsenault PR; Master SR; Lee FS
J Biol Chem; 2013 Apr; 288(14):9662-9674. PubMed ID: 23413029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]